West Pharmaceutical Services to Present at the CJS 25th Annual "New Ideas for the New Year" Investor Conference

Rhea-AI Summary

West Pharmaceutical Services (NYSE: WST), a leader in injectable drug administration solutions, has announced its participation in the upcoming CJS 25th Annual "New Ideas for the New Year" Virtual Investor Conference. The company will be represented by Cindy Reiss-Clark (Sr. VP and Chief Commercial Officer), Chad Winters (VP of Finance and Chief Accounting Officer), and John Sweeney (VP of Investor Relations).

The presentation is scheduled for January 14, 2025, at 10:15 a.m. ET. Investors and interested parties can access the live audio webcast through the Investors section of West Pharmaceutical's website at www.westpharma.com.

01/06/2025 - 04:30 PM

EXTON, Pa., Jan. 6, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that Cindy Reiss-Clark, Sr. VP and Chief Commercial Officer; Chad Winters, VP of Finance and Chief Accounting Officer; and John Sweeney, VP of Investor Relations, will present at the CJS 25^th Annual "New Ideas for the New Year" Virtual Investor Conference on January 14, 2025 at 10:15 a.m. ET.  

A live audio webcast will be available via the Investors section of our website, www.westpharma.com.

About West  
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With 10,000 team members across 50 sites worldwide, West helps support our customers by delivering approximately 43 billion components and devices each year.    

Headquartered in Exton, Pennsylvania, West in its fiscal year 2023 generated $2.95 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST) and is included in the Standard & Poor's 500 index. For more information, visit www.westpharma.com.  

All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted. 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/west-pharmaceutical-services-to-present-at-the-cjs-25th-annual-new-ideas-for-the-new-year-investor-conference-302343236.html

SOURCE West Pharmaceutical Services, Inc.

FAQ

When is West Pharmaceutical Services (WST) presenting at the CJS New Ideas conference 2025?

West Pharmaceutical Services will present at the CJS conference on January 14, 2025, at 10:15 a.m. ET.

Who are the WST executives presenting at the CJS 2025 investor conference?

Cindy Reiss-Clark (Sr. VP and Chief Commercial Officer), Chad Winters (VP of Finance and Chief Accounting Officer), and John Sweeney (VP of Investor Relations) will present at the conference.

How can investors access West Pharmaceutical's CJS conference presentation?

Investors can access the live audio webcast through the Investors section of West Pharmaceutical's website at www.westpharma.com.

What type of conference is WST participating in January 2025?

WST is participating in the CJS 25th Annual "New Ideas for the New Year" Virtual Investor Conference, which is a virtual investment conference.